| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 9.6k | $6.37 | $61.5k | | 06/06/2023 |
| 05/11/2023 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 12.3k | $2.77 | $34.2k | | 05/11/2023 |
| 05/11/2023 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 20k | $2.77 | $55.4k | | 05/11/2023 |
| 05/11/2023 | Unity Biotechnology, Inc. | UBX | Disposition | Stock Option (Right to Buy) | 20k | $10.60 | $212k | | 05/11/2023 |
| 05/11/2023 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 40k | $2.77 | $110.8k | | 05/11/2023 |
| 05/11/2023 | Unity Biotechnology, Inc. | UBX | Disposition | Stock Option (Right to Buy) | 24k | $99.60 | $2.4M | | 05/11/2023 |
| 05/11/2023 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 24k | $2.77 | $66.5k | | 05/11/2023 |
| 05/11/2023 | Unity Biotechnology, Inc. | UBX | Disposition | Stock Option (Right to Buy) | 12.3k | $41.80 | $515.5k | | 05/11/2023 |
| 12/13/2022 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 9.6k | $6.47 | $62.4k | | 12/13/2022 |
| 11/18/2022 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 80k | $2.38 | $190.4k | | 11/18/2022 |
| 06/10/2022 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $4.38 | $41k | | 06/10/2022 |
| 06/07/2022 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 51k | $0.63 | $31.9k | | 06/07/2022 |
| 05/15/2022 | Unity Biotechnology, Inc. | UBX | Other (acquisition) | Common Stock, $0.0001 par value | 925 | $6.89 | $6.4k | | 11/18/2022 |
| 03/29/2022 | BiomX Inc. | PHGE | Grant | Common Stock Options - Right to Buy | 20.5k | $1.41 | $28.9k | | 03/29/2022 |
| 02/09/2022 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 200k | $1.06 | $212k | | 02/09/2022 |
| 02/09/2022 | Unity Biotechnology, Inc. | UBX | Grant | Common Stock, $0.0001 par value | 50k | $0.00 | $0 | | 02/09/2022 |
| 07/28/2021 | BiomX Inc. | PHGE | Purchase | Common Stock | 12.5k | $4.00 | $50k | | 07/28/2021 |
| 07/28/2021 | BiomX Inc. | PHGE | Purchase | Common Stock Warrant | 9.4k | $5.00 | $46.9k | | 07/28/2021 |
| 06/24/2021 | Unity Biotechnology, Inc. | UBX | Grant | Common Stock, $0.0001 par value | 30.8k | $0.00 | $0 | | 06/24/2021 |
| 06/24/2021 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 123.3k | $4.18 | $515.5k | | 06/24/2021 |
| 06/23/2021 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $17.12 | $160.4k | | 06/23/2021 |
| 06/16/2021 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 30k | $3.94 | $118.2k | | 06/16/2021 |
| 03/30/2021 | BiomX Inc. | PHGE | Grant | Common Stock Options - Right to Buy | 15.2k | $7.02 | $106.7k | | 03/30/2021 |
| 09/13/2020 | Unity Biotechnology, Inc. | UBX | Grant | Common Stock, $0.0001 par value | 240k | $0.00 | $0 | | 09/13/2020 |
| 08/01/2020 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 240k | $9.96 | $2.4M | | 08/01/2020 |
| 07/23/2020 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $16.00 | $149.9k | | 07/23/2020 |
| 06/16/2020 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 30k | $3.03 | $90.9k | | 06/16/2020 |
| 06/03/2020 | Adicet Bio, Inc. | TORC | Grant | Stock Option (Right to Buy) | 14.4k | $2.23 | $32.1k | | 06/03/2020 |
| 03/25/2020 | BiomX Inc. | PHGE | Grant | Common Stock Options - Right to Buy | 16k | $6.21 | $99.4k | | 03/25/2020 |
| 06/13/2019 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 10k | $5.26 | $52.6k | | 06/13/2019 |
| 05/08/2019 | Adicet Bio, Inc. | TORC | Grant | Stock Option (Right to Buy) | 14.4k | $7.99 | $115.2k | | 05/08/2019 |
| 12/13/2018 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 8.2k | $23.58 | $192.5k | | 12/13/2018 |
| 07/25/2018 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 1.8k | $37.89 | $69.5k | | 07/25/2018 |